Search Results

There are 7686 results for: content related to: Modeling the antiviral activity of ribavirin against hepatitis C virus in cell culture

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2

    Hepatology Research

    Volume 46, Issue 2, February 2016, Pages: 129–165, Yasuhiro Asahina, Namiki Izumi, Kumada Hiromitsu, Masayuki Kurosaki, Kazuhiko Koike, Fumitaka Suzuki, Hajime Takikawa, Atsushi Tanaka, Eiji Tanaka, Yasuhito Tanaka, Hirohito Tsubouchi, Norio Hayashi, Naoki Hiramatsu and Hiroshi Yotsuyanagi

    Version of Record online : 15 FEB 2016, DOI: 10.1111/hepr.12645

  2. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  3. You have free access to this content
    Adenosine kinase is a key determinant for the anti-HCV activity of ribavirin

    Hepatology

    Volume 58, Issue 4, October 2013, Pages: 1236–1244, Kyoko Mori, Osamu Hiraoka, Masanori Ikeda, Yasuo Ariumi, Akiko Hiramoto, Yusuke Wataya and Nobuyuki Kato

    Version of Record online : 19 AUG 2013, DOI: 10.1002/hep.26421

  4. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  5. You have free access to this content
    Ribavirin improves the IFN-γ response of natural killer cells to IFN-based therapy of hepatitis C virus infection

    Hepatology

    Volume 60, Issue 4, October 2014, Pages: 1160–1169, Jens M. Werner, Elisavet Serti, Xenia Chepa-Lotrea, Jonathan Stoltzfus, Golo Ahlenstiel, Mazen Noureddin, Jordan J. Feld, T. Jake Liang, Yaron Rotman and Barbara Rehermann

    Version of Record online : 13 AUG 2014, DOI: 10.1002/hep.27092

  6. You have free access to this content
    Poster Session II (Abstracts 730 – 1194)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 361–601,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28798

  7. You have free access to this content
    Poster Session 2: Hepatitis C: Approved Therapeutic Agents

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 659A–709A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27516

  8. You have free access to this content
    Poster Session IV (Abstracts 1638 – 2112)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 811–1050,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28800

  9. You have free access to this content
    Poster Session 4: Hepatitis C: New Agents (Not Approved)

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1128A–1161A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27533

  10. You have free access to this content
    Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

    Hepatology

    Volume 62, Issue 3, September 2015, Pages: 932–954, AASLD/IDSA HCV Guidance Panel

    Version of Record online : 4 AUG 2015, DOI: 10.1002/hep.27950

  11. You have free access to this content
    Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials

    Hepatology

    Volume 62, Issue 1, July 2015, Pages: 25–30, Saleh A. Alqahtani, Nezam Afdhal, Stefan Zeuzem, Stuart C. Gordon, Alessandra Mangia, Paul Kwo, Michael Fried, Jenny C. Yang, Xiao Ding, Phillip S. Pang, John G. McHutchison, David Pound, K. Rajender Reddy, Patrick Marcellin, Kris V. Kowdley and Mark Sulkowski

    Version of Record online : 1 JUN 2015, DOI: 10.1002/hep.27890

  12. Macromolecular Prodrugs for Controlled Delivery of Ribavirin

    Macromolecular Bioscience

    Volume 14, Issue 2, February 2014, Pages: 173–185, Mille B. L. Kryger, Anton A. A. Smith, Benjamin M. Wohl and Alexander N. Zelikin

    Version of Record online : 17 SEP 2013, DOI: 10.1002/mabi.201300244

  13. Impact of ribavirin dosage in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin combination therapy

    Journal of Medical Virology

    Volume 88, Issue 10, October 2016, Pages: 1776–1784, Yuki Tahata, Naoki Hiramatsu, Tsugiko Oze, Ayako Urabe, Naoki Morishita, Ryoko Yamada, Takayuki Yakushijin, Atsushi Hosui, Masahide Oshita, Akira Kaneko, Hideki Hagiwara, Eiji Mita, Toshifumi Ito, Yukinori Yamada, Masami Inada, Kazuhiro Katayama, Shinji Tamura, Yasuharu Imai, Hayato Hikita, Ryotaro Sakamori, Yuichi Yoshida, Tomohide Tatsumi, Norio Hayashi and Tetsuo Takehara

    Version of Record online : 29 MAR 2016, DOI: 10.1002/jmv.24528

  14. You have free access to this content
    Administration of low-dose epoetin-alpha facilitates adherence to ribavirin in triple therapy with pegylated interferon-alpha-2b and telaprevir

    Hepatology Research

    Volume 44, Issue 10, October 2014, Pages: E84–E91, Hisashi Ishida, Sadatsugu Sakane, Takashi Toyama, Keisuke Fukutomi, Keiichi Kimura, Aya Sugimoto, Kenji Hibino, Takeshi Tamura, Tetsuya Iwasaki, Ryuichiro Iwasaki, Hiroko Hasegawa, Yuko Sakakibara, Takuya Yamada, Shoichi Nakazuru and Eiji Mita

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12224

  15. You have free access to this content
    Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials

    Hepatology

    Volume 61, Issue 6, June 2015, Pages: 1798–1808, Zobair M. Younossi, Maria Stepanova, Patrick Marcellin, Nezam Afdhal, Kris V. Kowdley, Stefan Zeuzem and Sharon L. Hunt

    Version of Record online : 18 MAR 2015, DOI: 10.1002/hep.27724

  16. Optimal dose of peginterferon and ribavirin for treatment of chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 15, Issue 9, September 2008, Pages: 623–633, M. Gambarin-Gelwan and I. M. Jacobson

    Version of Record online : 10 JUL 2008, DOI: 10.1111/j.1365-2893.2008.01018.x

  17. You have free access to this content
    A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results

    Hepatology

    Volume 50, Issue 3, September 2009, Pages: 717–726, Yves Benhamou, Nezam H. Afdhal, David R. Nelson, Mitchell L. Shiffman, Deanine G. Halliman, Jamie Heise, Eric Chun and Paul J. Pockros

    Version of Record online : 11 MAY 2009, DOI: 10.1002/hep.23073

  18. Effects of ribavirin monotherapy on the viral population in patients with chronic hepatitis C genotype 1: Direct sequencing and pyrosequencing of the HCV regions

    Journal of Medical Virology

    Volume 86, Issue 11, November 2014, Pages: 1886–1897, R. Quiles-Pérez, P. Muñoz-de-Rueda, A. Martín-Lagos Maldonado, A. Martín-Álvarez, J. Quer and J. Salmerón

    Version of Record online : 5 AUG 2014, DOI: 10.1002/jmv.24035

  19. You have free access to this content
    ITPA genotype protects against anemia during peginterferon and ribavirin therapy but does not influence virological response

    Hepatology

    Volume 59, Issue 6, June 2014, Pages: 2152–2160, Jacinta A. Holmes, Stuart K. Roberts, Rachel J. Ali, Gregory J. Dore, William Sievert, Geoffrey W. McCaughan, Darrell H. Crawford, Wendy S. Cheng, Martin D. Weltman, Sara Bonanzinga, Kumar Visvanathan, Vijaya Sundararajan, Paul V. Desmond, D. Scott Bowden, Gail V. Matthews, Alexander J. Thompson and on behalf of the CHARIOT Study Group

    Version of Record online : 25 APR 2014, DOI: 10.1002/hep.27022

  20. You have free access to this content
    Ribavirin modulates the conversion of human CD4+ CD25T cell to CD4+ CD25+ FOXP3+T cell via suppressing interleukin-10-producing regulatory T cell

    Immunology

    Volume 137, Issue 3, November 2012, Pages: 259–270, Tamaki Kobayashi, Katsuhisa Nakatsuka, Masumi Shimizu, Hideto Tamura, Eiji Shinya, Masanori Atsukawa, Hirotomo Harimoto, Hidemi Takahashi and Choitsu Sakamoto

    Version of Record online : 2 OCT 2012, DOI: 10.1111/imm.12005